論韓國2026年菸品定義擴張與新興毒品霧化載體監理對我國之啟示【全球暸望】 試閱
Regulating Novel Tobacco Products and Drug-Vaping Vectors: Lessons from South Korea's 2026 Reforms for Taiwan
新興菸品與合成尼古丁產品的迅速崛起與擴散，使既有之菸害管制政策追趕不及，凸顯出健康法學上科技領先於法律的「監理滯後」困境。本文以韓國2026年4月施行之《菸草事業法》與《國民健康增進法》重大修正為核心，分析其如何將菸品之管制思維，自傳統的「植物原料溯源模式」，擴張為以「成癮性活性物質」為核心的管理模式。藉由把合成尼古丁也正式納入管轄，韓國實務上建構起「設備與煙彈一體化監理」、「成分雙年檢測與數據公開」、「網路全面禁售」與「平臺守門人責任」之多層防禦體系。本文進一步檢視韓國面對依托咪酯（俗稱喪屍煙彈）此類新興毒品霧化載體危機時，所採取之「預防性超前納管」、「暫定毒品制度」及「NIMS醫療流向綁定」等刑事與公共衛生（下稱公衛）交織政策。本文據以主張，我國之體系困局，其根源在於管制客體之錯置而非管制強度之不足；在菸品定義未由「原料溯源」與「外觀擬制」轉向「活性物質管理」之前，刑罰化、持有處罰、沒入沒收與平臺課責等各項工具，均不過係疊加於同一錯誤基礎之上，難期發揮其宣稱之防堵效果。期本文能為我國於數位時代因應伴隨科技創新而來之新興公共衛生風險，築起實效之公衛防線。
The rapid emergence and proliferation of novel tobacco products and synthetic nicotine products have outpaced traditional tobacco control policies, highlighting the regulatory lag inherent in health law, where technological innovation outpaces the law. Taking the major 2026 amendments to South Korea’s Tobacco Business Act and National Health Promotion Act (effective April 2026) as its focus, this article analyzes how these reforms shifted the regulatory paradigm for tobacco products from a traditional plant-material source-tracing model to one centered on the management of addictive active substances. Through this shift, synthetic nicotine was also formally brought within the scope of regulation, and a multi-layered defensive framework was established, comprising the integrated regulation of devices and pods, biennial constituent testing with public disclosure of data, a comprehensive ban on online sales, and platform gatekeeper liability. This article further examines South Korea’s responses to the crisis posed by drug-vaping vectors such as Etomidate (so-called “K-POD, zombie vapes”), including its strategy of precautionary anticipatory scheduling, the temporary controlled-substance designation system, and the mandatory binding of medical-supply flows to the Narcotics Information Management System (NIMS). This article argues that Taiwan’s regulatory impasse originates not from insufficient regulatory intensity but from a misidentified object of regulation: so long as the statutory definition of tobacco products remains anchored in plant-material source-tracing and in the resemblance of a device’s outward form, the criminalisation of supply, the penalisation of possession, confiscation regimes and platform liability alike are merely layered upon the same defective foundation. It thereby seeks to offer regulatory lessons for Taiwan in countering novel tobacco products and emerging drug-vaping vectors, to effectively address the public health risks that accompany technological innovation, and to build a robust public health defense line in the digital age.
077-103
